Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4149/BLL_2021_096 http://scihub22266oqcxt.onion/10.4149/BLL_2021_096 34282628!ä!34282628 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Bratisl+Lek+Listy 2021 ; 122 (8): 598-604 Nephropedia Template TP {{tp|p=34282628|t=2021. Evaluation of index of cardiac electrophysiological balance in COVID-19 patients |pdf=|usr=}}{{34282628}} gab.com Text Evaluation of index of cardiac electrophysiological balance in COVID-19 patients JO: Bratisl Lek Listy http://www.kidney.de/pget.php?&tw=1&pmid=34282628 #FOAvip AIM: The aim of the current study was to evaluate the index of Cardiac Electrophysiological Balance (iCEB) in hospitalized COVID-19 patients receiving Hydroxychloroquine / azithromycin (HCQ / AZ) combination therapy to determine the susceptibility to ventricular arrhythmia among these patients. METHOD: Sixty-seven COVID-19 patients admitted to the ward were included in the study. Electrocardiograms (ECGs) were obtained from all patients before the initiation of treatment and on treatment day 5. QT/QRS (iCEB) and QTc/QRS (iCEBc) ratios were calculated. RESULTS: QRS, QT and QTc intervals were significantly prolonged on day 5 measurements compared to pre-treatment period (p <0.05). Overall, mean iCEB was 3.6+/-0.4 before treatment and 3.8+/-0.4 on day 5 in the study population (p <0.001). Considering the iCEBc values, a significant increase was observed in patients receiving HCQ/AZ treatment compared to pre-treatment period (4.1+/-0.5 vs 4.4+/-0.6; p <0.001). CONCLUSIONS: To the best of our knowledge, this was the first study to investigate iCEB and iCEBc parameters in patients with COVID-19 on HCQ/AZ therapy. In this study, we demonstrated significantly increased iCEB and iCEBc values following HCQ/AZ treatment in COVID-19 patients. iCEB and iCEBc may serve as a noninvasive, simple, and novel biomarker for detecting increased pro-arrhythmia risk in COVID-19 patients (Tab. 3, Fig. 3, Ref. 36). Twit Text FOAVip Evaluation of index of cardiac electrophysiological balance in COVID-19 patients ????Bratisl Lek Listy http://www.kidney.de/pget.php?&tw=1&pmid=34282628 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34282628 #FOAvip English Wikipedia <ref>{{Cite pmid|34282628}}</ref> Evaluation of index of cardiac electrophysiological balance in COVID-19 patients #MMPMID34282628 Asoglu R; Tibilli H; Asoglu E; Aladag N; Ozdemir M; Suner A Bratisl Lek Listy 2021[]; 122 (8): 598-604 PMID34282628show ga AIM: The aim of the current study was to evaluate the index of Cardiac Electrophysiological Balance (iCEB) in hospitalized COVID-19 patients receiving Hydroxychloroquine / azithromycin (HCQ / AZ) combination therapy to determine the susceptibility to ventricular arrhythmia among these patients. METHOD: Sixty-seven COVID-19 patients admitted to the ward were included in the study. Electrocardiograms (ECGs) were obtained from all patients before the initiation of treatment and on treatment day 5. QT/QRS (iCEB) and QTc/QRS (iCEBc) ratios were calculated. RESULTS: QRS, QT and QTc intervals were significantly prolonged on day 5 measurements compared to pre-treatment period (p <0.05). Overall, mean iCEB was 3.6+/-0.4 before treatment and 3.8+/-0.4 on day 5 in the study population (p <0.001). Considering the iCEBc values, a significant increase was observed in patients receiving HCQ/AZ treatment compared to pre-treatment period (4.1+/-0.5 vs 4.4+/-0.6; p <0.001). CONCLUSIONS: To the best of our knowledge, this was the first study to investigate iCEB and iCEBc parameters in patients with COVID-19 on HCQ/AZ therapy. In this study, we demonstrated significantly increased iCEB and iCEBc values following HCQ/AZ treatment in COVID-19 patients. iCEB and iCEBc may serve as a noninvasive, simple, and novel biomarker for detecting increased pro-arrhythmia risk in COVID-19 patients (Tab. 3, Fig. 3, Ref. 36). |*COVID-19[MESH] |*Long QT Syndrome[MESH] |Arrhythmias, Cardiac/chemically induced/diagnosis[MESH] |Azithromycin[MESH] |Electrocardiography[MESH] |Humans[MESH]Evaluation of index of cardiac electrophysiological balance in COVID-1(epmc).pdf DeepDyve Pubget Overpricing